These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9436858

  • 1. Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
    Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH.
    Pancreas; 1998 Jan; 16(1):19-25. PubMed ID: 9436858
    [Abstract] [Full Text] [Related]

  • 2. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
    Mohammad RM, Li Y, Mohamed AN, Pettit GR, Adsay V, Vaitkevicius VK, Al-Katib AM, Sarkar FH.
    Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
    [Abstract] [Full Text] [Related]

  • 3. Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.
    Mohammad RM, Adsay NV, Philip PA, Pettit GR, Vaitkevicius VK, Sarkar FH.
    Anticancer Drugs; 2001 Oct; 12(9):735-40. PubMed ID: 11593055
    [Abstract] [Full Text] [Related]

  • 4. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
    Mohammad RM, Mohamed AN, Hamdan MY, Vo T, Chen B, Katato K, Abubakr YA, Dugan MC, al-Katib A.
    Leukemia; 1996 Jan; 10(1):130-7. PubMed ID: 8558918
    [Abstract] [Full Text] [Related]

  • 5. An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.
    Mohammad RM, Al-Katib A, Pettit GR, Vaitkevicius VK, Joshi U, Adsay V, Majumdar AP, Sarkar FH.
    Clin Cancer Res; 1998 Apr; 4(4):887-94. PubMed ID: 9563882
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer.
    He Z, Evelhoch JL, Mohammad RM, Adsay NV, Pettit GR, Vaitkevicius VK, Sarkar FH.
    Pancreas; 2000 Jul; 21(1):69-76. PubMed ID: 10881935
    [Abstract] [Full Text] [Related]

  • 7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 8. A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.
    Mohammad RM, Limvarapuss C, Wall NR, Hamdy N, Beck FW, Pettit GR, Al-Katib A.
    Int J Oncol; 1999 Aug 15; 15(2):367-72. PubMed ID: 10402249
    [Abstract] [Full Text] [Related]

  • 9. Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion.
    Starr AN, Vexler A, Marmor S, Konik D, Ashkenasi-Voghera M, Lev-Ari S, Greif Y, Ben-Yosef R.
    Oncology; 2005 Aug 15; 69(3):239-45. PubMed ID: 16141719
    [Abstract] [Full Text] [Related]

  • 10. [Establishment of a human pancreatic adenocarcinoma cell line(JF305) with p53 expression].
    Li X, Wang H, Jiang Y.
    Zhonghua Zhong Liu Za Zhi; 1994 May 15; 16(3):181-3. PubMed ID: 7956694
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A.
    Clin Cancer Res; 1998 May 15; 4(5):1337-43. PubMed ID: 9607595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
    Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Penas EM, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Effenberger KE, Bockhorn M, Izbicki JR, Yekebas EF.
    BMC Cancer; 2010 Jun 16; 10():295. PubMed ID: 20553613
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An orthotopic in vivo model of human pancreatic cancer.
    Schwarz RE, McCarty TM, Peralta EA, Diamond DJ, Ellenhorn JD.
    Surgery; 1999 Sep 16; 126(3):562-7. PubMed ID: 10486610
    [Abstract] [Full Text] [Related]

  • 16. Propagation of Waldenström's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drug screening model.
    al-Katib A, Mohammad R, Hamdan M, Mohamed AN, Dan M, Smith MR.
    Blood; 1993 Jun 01; 81(11):3034-42. PubMed ID: 8499639
    [Abstract] [Full Text] [Related]

  • 17. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
    Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, Sethi S, Aboukameel A, Kiousis S, Zitron IM, Ebrahim SA, Polin LA, Sarkar FH, Bollig-Fischer A, Mittal S.
    J Transl Med; 2015 Jul 15; 13():227. PubMed ID: 26174772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.